Biopharmaceutical Translation and Biosimilars is an international, peer-reviewed, open access, semiannual journal dedicated to advancing research in biologics, biosimilars, and translational biopharmaceutical sciences. The journal publishes original research articles, reviews, short communications, and perspectives that bridge basic discovery, product development, regulatory science, and clinical implementation.The journal focuses on biologics and biosimilars, including recombinant proteins, monoclonal antibodies, antibody-drug conjugates, therapeutic peptides, and emerging biopharmaceutical platforms. It welcomes studies related to product characterization, analytical comparability, immunogenicity, pharmacokinetics, manufacturing, regulatory pathways, and clinical translation. Read More.